These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 23220105

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer.
    Asmus LR, Kaufmann B, Melander L, Weiss T, Schwach G, Gurny R, Möller M.
    Eur J Pharm Biopharm; 2012 Aug; 81(3):591-9. PubMed ID: 22561956
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A phase II trial with new triptorelin sustained release formulations in prostatic carcinoma.
    Minkov NK, Zozikov BI, Yaneva Z, Uldry PA.
    Int Urol Nephrol; 2001 Aug; 33(2):379-83. PubMed ID: 12092661
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
    Xie B, Jin L, Luo Z, Yu J, Shi S, Zhang Z, Shen M, Chen H, Li X, Song Z.
    Int J Pharm; 2015 Jul 25; 490(1-2):375-83. PubMed ID: 26027491
    [Abstract] [Full Text] [Related]

  • 11. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
    Ahmed TA, Ibrahim HM, Ibrahim F, Samy AM, Kaseem A, Nutan MT, Hussain MD.
    J Pharm Sci; 2012 Oct 25; 101(10):3753-62. PubMed ID: 22753324
    [Abstract] [Full Text] [Related]

  • 12. Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior.
    Astaneh R, Erfan M, Moghimi H, Mobedi H.
    J Pharm Sci; 2009 Jan 25; 98(1):135-45. PubMed ID: 18493999
    [Abstract] [Full Text] [Related]

  • 13. Controlled release of alendronate from polymeric films.
    Long KA, Jackson JK, Yang C, Chehroudi B, Brunette DM, Burt HM.
    J Biomater Sci Polym Ed; 2009 Jan 25; 20(5-6):653-72. PubMed ID: 19323882
    [Abstract] [Full Text] [Related]

  • 14. Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins.
    Desai KG, Olsen KF, Mallery SR, Stoner GD, Schwendeman SP.
    Pharm Res; 2010 Apr 25; 27(4):628-43. PubMed ID: 20148292
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Formulation and evaluation of an in situ gel forming system for controlled delivery of triptorelin acetate.
    Abashzadeh Sh, Dinarvand R, Sharifzadeh M, Hassanzadeh G, Amini M, Atyabi F.
    Eur J Pharm Sci; 2011 Nov 20; 44(4):514-21. PubMed ID: 21946260
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in Rats.
    Dahmana N, Kowalczuk L, Gabriel D, Behar-Cohen F, Gurny R, Kalia YN.
    Mol Pharm; 2020 Jan 06; 17(1):59-69. PubMed ID: 31751144
    [Abstract] [Full Text] [Related]

  • 20. Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study.
    Mondon K, Zeisser-Labouèbe M, Gurny R, Möller M.
    Eur J Pharm Biopharm; 2011 Jan 06; 77(1):56-65. PubMed ID: 20888909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.